One missing metabolic step can turn cancer's DNA-copying machinery into a lethal weakness
Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their vulnerability to a class of anticancer drugs known as PARP inhibitors, a study led by UT Southwestern Medical Center researchers shows.
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · cyber
- [CYBER] Up to 700,000 daily cyberattacks from Iran-linked hackers, UAE warns
- [CYBER] CISA flags actively exploited ‘Copy Fail’ Linux kernel flaw enabling root takeover across major distros — unpatched systems may remain vulnerable to attack
- [CYBER] They don’t hack, they borrow: How fraudsters target credit unions
- [CYBER] Cyber Security Education as Self-Defence classes
- [CYBER] CVE-2026-7482 - Ollama heap out-of-bounds read in GGUF tensor parsing leaks server process memory to unauthenticated remote attackers
- [CYBER] CVE-2026-34059 - Apache HTTP Server: mod_proxy_ajp: Heap Over-Read and memory disclosure in ajp_parse_data()